Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 21, Issue 2

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 21, Issue 2 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 21, Issue 2 (2012)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Volume 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Rapalogs in viral cancers

Dirk P Dittmer, Aadra P Bhatt & Blossom Damania

Pages: 135-138

Published online: 04 Jan 2012

AbstractforRapalogs in viral cancers | Full Text | References | PDF (300.7 KB)

645 Views
6 CrossRef citations
0Altmetric

Free Access

Editorial

PDGF receptor blocker for pulmonary hypertension: a new agent in therapeutic arsenal

Rajamma Mathew MD

Pages: 139-142

Published online: 05 Jan 2012

First Page PreviewforPDGF receptor blocker for pulmonary hypertension: a new agent in therapeutic arsenal | Full Text | References | PDF (221.2 KB)

649 Views
4 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Drugs in preclinical and early-stage clinical development for pancreatic cancer

Swapna Asuthkar, Jasti S Rao & Christopher S Gondi

Pages: 143-152

Published online: 05 Jan 2012

AbstractforDrugs in preclinical and early-stage clinical development for pancreatic cancer | Full Text | References | PDF (274.8 KB)

474 Views
25 CrossRef citations
0Altmetric

Review Article

New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

Fabio Blandini & Marie-Therese Armentero

Pages: 153-168

Published online: 11 Jan 2012

AbstractforNew pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors | Full Text | References | PDF (409.2 KB)

631 Views
54 CrossRef citations
0Altmetric

Review Article

Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances

Ziva D Cooper PhD, Jermaine D Jones PhD & Sandra D Comer PhD

Pages: 169-178

Published online: 11 Jan 2012

AbstractforGlial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances | Full Text | References | PDF (221.2 KB)

398 Views
40 CrossRef citations
0Altmetric

Review Article

New agents for acute myeloid leukemia: is it time for targeted therapies?

Felicetto Ferrara MD

Pages: 179-189

Published online: 05 Jan 2012

AbstractforNew agents for acute myeloid leukemia: is it time for targeted therapies? | Full Text | References | PDF (233 KB)

642 Views
14 CrossRef citations
0Altmetric

Review Article

Targeting the subtypes of breast cancer: rethinking investigational drugs

Giuseppe Curigliano MD PhD, Marzia Locatelli, Luca Fumagalli, Janaina Brollo, Elisabetta Munzone, Franco Nolé, Carmen Criscitiello & Aron Goldhirsch

Pages: 191-204

Published online: 10 Jan 2012

AbstractforTargeting the subtypes of breast cancer: rethinking investigational drugs | Full Text | References | PDF (395.1 KB)

409 Views
1 CrossRef citations
0Altmetric

Review Article

Brentuximab Vedotin (SGN-35), an antibody–drug conjugate for the treatment of CD30-positive malignancies

Antonio Gualberto MD PhD

Pages: 205-216

Published online: 30 Nov 2011

AbstractforBrentuximab Vedotin (SGN-35), an antibody–drug conjugate for the treatment of CD30-positive malignancies | Full Text | References | PDF (365.7 KB)

1453 Views
63 CrossRef citations
0Altmetric

Drug Evaluations

Article

Pazopanib for the treatment of breast cancer

Laleh Amiri-Kordestani, Antoinette R Tan & Sandra M Swain

Pages: 217-225

Published online: 10 Jan 2012

Abstractfor Pazopanib for the treatment of breast cancer | Full Text | References | PDF (264.1 KB)

411 Views
11 CrossRef citations
0Altmetric

Article

MDV3100 for the treatment of prostate cancer

Deborah Mukherji, Carmel J Pezaro & Johann S De-Bono

Pages: 227-233

Published online: 10 Jan 2012

Abstractfor MDV3100 for the treatment of prostate cancer | Full Text | References | PDF (214.7 KB)

1086 Views
25 CrossRef citations
0Altmetric

Article

Misoprostol for the prevention and treatment of postpartum hemorrhage

Wendy R Sheldon MPH MSW, Jennifer Blum MPH, Jill Durocher & Beverly Winikoff MD MPH

Pages: 235-250

Published online: 11 Jan 2012

Abstractfor Misoprostol for the prevention and treatment of postpartum hemorrhage | Full Text | References | PDF (248.4 KB)

651 Views
21 CrossRef citations
0Altmetric

Article

Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer

Vladimir Yutkin MD & Joseph Chin MD

Pages: 251-260

Published online: 21 Dec 2011

Abstractfor Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer | Full Text | References | PDF (256.9 KB)

170 Views
12 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.21, Iss.2, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?